AKEBIA THERAPEUTICS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 25 Feb 2025)
What this means for you
Registered since 04 Dec 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86217725
- Registration number
- 5622940
- Mark type
- Stylized text
- Filed
- 11 Mar 2014
- Published for opposition
- 14 Jul 2015
- Registered
- 04 Dec 2018
- Attorney of record
- John L. DuPre'
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of hematological conditions and diseases, and pharmaceutical preparations for the treatment of chronic conditions, namely, chronic kidney disease, and all types of anemias
Owner
- Akebia Therapeutics, Inc., Cambridge, MA, US
- Akebia Therapeutics, Inc., Cambridge, MA, US
- Akebia Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 25 Feb 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 25 Feb 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 25 Feb 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 21 Oct 2024 — TEAS SECTION 8 & 15 RECEIVED
- 04 Dec 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 18 Apr 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 18 Apr 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 Apr 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 18 Apr 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 18 Apr 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 04 Dec 2018 — REGISTERED-PRINCIPAL REGISTER
- 30 Oct 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 Oct 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Sept 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 05 Sept 2018 — USE AMENDMENT FILED